Yan Li



  1. Gao Q, Li Y, Li M. The potential role of IL-33/ST2 signaling in fibrotic diseases. J Leukoc Biol. 2015;98:15-22 pubmed publisher
    ..In this review, the biologic characteristics of IL-33 and the role of the IL-33/ST2 signaling pathway in various fibrotic diseases will be discussed. We hope this overview will provide new insights for the treatment of these diseases. ..
  2. Wang Y, Zhou M, Zeng L, Gao Q, Yuan X, Li Y, et al. Soluble expression and one-step purification of recombinant mouse interferon-λ3 in Escherichia coli. Biochemistry (Mosc). 2015;80:228-32 pubmed publisher
    ..Our findings show that the production of soluble IFN-λ3 proteins by the pET-44 vector in Escherichia coli is a good alternative for the production of native IFN-λ3 and could be useful for the production of other IFN proteins. ..
  3. Gao Q, Li Y, Pan X, Yuan X, Peng X, Li M. Lentivirus expressing soluble ST2 alleviates bleomycin-induced pulmonary fibrosis in mice. Int Immunopharmacol. 2016;30:188-193 pubmed publisher
    ..This study suggests that lentivirus expressing soluble ST2 might represent an effective therapeutic approach in the treatment of pulmonary fibrotic diseases. ..
  4. Gu J, Gao X, Pan X, Peng X, Li Y, Li M. High-level expression and one-step purification of a soluble recombinant human interleukin-37b in Escherichia coli. Protein Expr Purif. 2015;108:18-22 pubmed publisher
    ..Thus, this method provides an efficient way to obtain an active IL-37 with high yield and high purity. ..